Immunotherapy for lymphoma / 国际肿瘤学杂志
Journal of International Oncology
;
(12): 633-637, 2017.
Article
in Chinese
| WPRIM
| ID: wpr-657252
ABSTRACT
At present,immunotherapies for lymphoma are becoming gradually important.Chimeric antigen receptor-modified T cells therapy,bispecific antibody and immune-checkpoint inhibitor are considered as breakthrough treatments,each has its own unique mechanism,and more advanced treatments will be developed based on them.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Journal of International Oncology
Year:
2017
Type:
Article
Similar
MEDLINE
...
LILACS
LIS